<DOC>
	<DOCNO>NCT00131846</DOCNO>
	<brief_summary>The purpose DIME evaluate safety ( i.e . new onset diabetes metabolic adverse event ) , efficacy cost-effectiveness antihypertensive treatment low dose diuretic . The researcher ' hypothesis use low dose thiazide diuretic metabolically safe use appropriate antihypertensive , effective reduction blood pressure cheap treatment without diuretic . Therefore , study equivalence trial .</brief_summary>
	<brief_title>Diuretics In Management Essential Hypertension ( DIME ) Study</brief_title>
	<detailed_description>There substantial evidence clinical trial support rationale use thiazide diuretic patient essential hypertension . Diuretics may effective reduction blood pressure Japanese patient Caucasian high salt intake . Moreover , give large number hypertensive population , diuretic may cost-effective antihypertensive agent . Japanese physician , however , tend avoid diuretic even elderly hypertensive patient much concern metabolic adverse event include new onset diabetes , deem increase cardiovascular risk . Although unlikely use low dose ( 12.5 mg HCTZ le ) diuretic associate metabolic adverse event give appropriate antihypertensive agent ( e.g . Ca antagonist , ACE inhibitor , ARB , K spar diuretic ) β-blockers , researcher confirm safety low dose diuretic term new onset diabetes Japanese , assume `` diabetes prone '' base upon thrifty gene hypothesis .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Sodium Chloride Symporter Inhibitors</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>Aged 30 79 year With blood pressure &gt; 150/ &gt; 90 antihypertensive treatment With blood pressure &gt; 140/ &gt; 90 already antihypertensive drug No history type 2 diabetes No history gout With supine blood pressure &gt; 200/ &gt; 120 Patients already antihypertensive treatment duration treatment drug use identified Patients already thiazide diuretic With type 2 diabetes With gout hyperuricaemia ( &gt; 8.0 mg/dl ) With hypokalemia（ &lt; 3.5mmol/L） With erectile dysfunction With renal dysfunction ( screatinine &gt; 2.0 mg/dL ) With history serious adverse reaction thiazide diuretic With history stroke myocardial infarction within 6 month With history percutaneous coronary intervention ( PCI ) coronary artery bypass graft ( CABG ) within 6 month intervention plan With heart failure leave ventricular dysfunction ( ejection fraction &lt; 40 % ) Patients thiazide diuretic With history malignant tumor within 5 year Pregnant , possibility pregnancy , breast feeding Patients deem eligible study reason</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Thiazide diuretic</keyword>
	<keyword>Essential hypertension</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Randomized clinical trial</keyword>
	<keyword>Cost-effectiveness</keyword>
</DOC>